Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Aug;80(12):1982–1986. doi: 10.1038/sj.bjc.6690631

DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers

H Iwase 1, Y Omoto 1, H Iwata 1, T Toyama 1, Y Hara 1, Y Ando 1, Y Ito 1, Y Fujii 1, S Kobayashi 1
PMCID: PMC2374276  PMID: 10471050

Abstract

Oestrogen receptor α (ER-α) gene has two specific promoters, distal (P0) and proximal (P1), which induce almost identical transcripts in size due to different splicing. We examined the methylation at both promoter regions of the ER-α gene using HpaII, a methylation-sensitive restriction enzyme, prior to polymerase chain reaction (PCR) amplification. To confirm the results of PCR-based methylation analysis, Southern hybridization was also performed. Twenty of 29 patients with ER-α-positive tumours and five of 27 with ER-α-negative tumours were unmethylated at the P1 promoter region of the ER-α gene. The incidence of methylation was highly negatively correlated with ER-α expression (P = 0.0002). A similarly negative correlation was observed at the P0 promoter region of the ER-α gene (P = 0.0154). Additionally, the tumours with the ER-α gene hypermethylated at both promoter regions had definitely negative ER-α values. It was suggested that this epigenetic change might control ER-α expression, and might play an important role in the loss of hormone-dependence in breast cancer. © 1999 Cancer Research Campaign

Keywords: oestrogen receptor α, DNA methylation, hormone resistance, breast cancer

Full Text

The Full Text of this article is available as a PDF (193.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahuja N., Mohan A. L., Li Q., Stolker J. M., Herman J. G., Hamilton S. R., Baylin S. B., Issa J. P. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res. 1997 Aug 15;57(16):3370–3374. [PubMed] [Google Scholar]
  2. Baylin S. B., Herman J. G., Graff J. R., Vertino P. M., Issa J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141–196. [PubMed] [Google Scholar]
  3. Chen Z., Ko A., Yang J., Jordan V. C. Methylation of CpG island is not a ubiquitous mechanism for the loss of oestrogen receptor in breast cancer cells. Br J Cancer. 1998;77(2):181–185. doi: 10.1038/bjc.1998.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Falette N. S., Fuqua S. A., Chamness G. C., Cheah M. S., Greene G. L., McGuire W. L. Estrogen receptor gene methylation in human breast tumors. Cancer Res. 1990 Jul 1;50(13):3974–3978. [PubMed] [Google Scholar]
  5. Ferguson A. T., Lapidus R. G., Baylin S. B., Davidson N. E. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res. 1995 Jun 1;55(11):2279–2283. [PubMed] [Google Scholar]
  6. Ferguson A. T., Vertino P. M., Spitzner J. R., Baylin S. B., Muller M. T., Davidson N. E. Role of estrogen receptor gene demethylation and DNA methyltransferase.DNA adduct formation in 5-aza-2'deoxycytidine-induced cytotoxicity in human breast cancer cells. J Biol Chem. 1997 Dec 19;272(51):32260–32266. doi: 10.1074/jbc.272.51.32260. [DOI] [PubMed] [Google Scholar]
  7. Gonzalez-Zulueta M., Bender C. M., Yang A. S., Nguyen T., Beart R. W., Van Tornout J. M., Jones P. A. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 1995 Oct 15;55(20):4531–4535. [PubMed] [Google Scholar]
  8. Grandien K., Bäckdahl M., Ljunggren O., Gustafsson J. A., Berkenstam A. Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell lines. Endocrinology. 1995 May;136(5):2223–2229. doi: 10.1210/endo.136.5.7720671. [DOI] [PubMed] [Google Scholar]
  9. Hayashi S., Imai K., Suga K., Kurihara T., Higashi Y., Nakachi K. Two promoters in expression of estrogen receptor messenger RNA in human breast cancer. Carcinogenesis. 1997 Mar;18(3):459–464. doi: 10.1093/carcin/18.3.459. [DOI] [PubMed] [Google Scholar]
  10. Hennig G., Behrens J., Truss M., Frisch S., Reichmann E., Birchmeier W. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene. 1995 Aug 3;11(3):475–484. [PubMed] [Google Scholar]
  11. Iwase H., Greenman J. M., Barnes D. M., Bobrow L., Hodgson S., Mathew C. G. Loss of heterozygosity of the oestrogen receptor gene in breast cancer. Br J Cancer. 1995 Mar;71(3):448–450. doi: 10.1038/bjc.1995.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Iwase H., Greenman J. M., Barnes D. M., Hodgson S., Bobrow L., Mathew C. G. Sequence variants of the estrogen receptor (ER) gene found in breast cancer patients with ER negative and progesterone receptor positive tumors. Cancer Lett. 1996 Nov 29;108(2):179–184. doi: 10.1016/s0304-3835(96)04406-0. [DOI] [PubMed] [Google Scholar]
  13. Johnston S. R., Saccani-Jotti G., Smith I. E., Salter J., Newby J., Coppen M., Ebbs S. R., Dowsett M. Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Res. 1995 Aug 1;55(15):3331–3338. [PubMed] [Google Scholar]
  14. Karnik P. S., Kulkarni S., Liu X. P., Budd G. T., Bukowski R. M. Estrogen receptor mutations in tamoxifen-resistant breast cancer. Cancer Res. 1994 Jan 15;54(2):349–353. [PubMed] [Google Scholar]
  15. Katzenellenbogen B. S., Montano M. M., Ekena K., Herman M. E., McInerney E. M. William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer. Breast Cancer Res Treat. 1997 May;44(1):23–38. doi: 10.1023/a:1005835428423. [DOI] [PubMed] [Google Scholar]
  16. Lapidus R. G., Nass S. J., Butash K. A., Parl F. F., Weitzman S. A., Graff J. G., Herman J. G., Davidson N. E. Mapping of ER gene CpG island methylation-specific polymerase chain reaction. Cancer Res. 1998 Jun 15;58(12):2515–2519. [PubMed] [Google Scholar]
  17. McGuire W. L., Chamness G. C., Fuqua S. A. Estrogen receptor variants in clinical breast cancer. Mol Endocrinol. 1991 Nov;5(11):1571–1577. doi: 10.1210/mend-5-11-1571. [DOI] [PubMed] [Google Scholar]
  18. Ottaviano Y. L., Issa J. P., Parl F. F., Smith H. S., Baylin S. B., Davidson N. E. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res. 1994 May 15;54(10):2552–2555. [PubMed] [Google Scholar]
  19. Roodi N., Bailey L. R., Kao W. Y., Verrier C. S., Yee C. J., Dupont W. D., Parl F. F. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J Natl Cancer Inst. 1995 Mar 15;87(6):446–451. doi: 10.1093/jnci/87.6.446. [DOI] [PubMed] [Google Scholar]
  20. Watts C. K., Handel M. L., King R. J., Sutherland R. L. Oestrogen receptor gene structure and function in breast cancer. J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):529–536. doi: 10.1016/0960-0760(92)90378-v. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES